Stock of the Day
April 29, 2021
Agios Pharmaceuticals (AGIO)
$34.06
+$0.48 (+1.4%)
Market Cap:
$1.97B
About Agios Pharmaceuticals
Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias.
The company develops AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias; and AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria. Its preclinical product is siRNA for the treatment of polycythemia vera, a rare blood disorder. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
← Previous Stock of the Day
Next Stock of the Day →
Recent News
Vertex (VRTX) Down 0.8% Since Last Earnings Report: Can It Rebound?
(msn.com)